11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Nuclear Medicine

• Publication date

  2006-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 17015906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis of 1‐(2,4‐dichlorophenyl)‐4‐cyano‐5‐(4‐[11C]methoxyphenyl)‐N‐(piperidin‐1‐yl)‐1H‐pyrazole‐3‐carboxamide ([11C]JHU75528) and 1‐(2‐bromophenyl)‐4‐cyano‐5‐(4‐[11C]methoxyphenyl)‐N‐(piperidin‐1‐yl)‐1H‐pyrazole‐3‐carboxamide ([11C]JHU75575) as potential radioligands for PET imaging of cerebral

  2006cited by this paper
• Cannabinoid CB1 receptors control conditioned drug seeking.

  2005cited by this paper
• Cannabinoids and the regulation of ingestive behaviour.

  2005cited by this paper
• levated Levels of Endocannabinoids and CB1 eceptor-Mediated G-Protein Signaling in the refrontal Cortex of Alcoholic Suicide Victims

  2005cited by this paper
• Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

  2005cited by this paper
• The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

  2005influential reference
• Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans.

  2005cited by this paper
• Cannabinoids and the regulation of ingestive behaviour.

  2005cited by this paper
• Candidate PET radioligands for cannabinoid CB1 receptors: [18F]AM5144 and related pyrazole compounds.

  2005cited by this paper
• A role for cannabinoid CB1 receptors in mood and anxiety disorders

  2005cited by this paper
• Cannabinoid Receptors and Their Relationships with Neuropsychiatric Disorders

  2005cited by this paper
• New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia.

  2004cited by this paper
• Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims

  2004cited by this paper
• [123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients.

  2004cited by this paper
• Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure

  2004cited by this paper
• Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia.

  2004cited by this paper
• Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes.

  2003cited by this paper
• Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography.

  2003cited by this paper
• Regioselective F‐18 radiolabeling of AM694, a CB1 cannabinoid receptor ligand

  2003cited by this paper
• Drug Discovery Strategies and Methods

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• In silico prediction of blood-brain barrier permeation.

  2003cited by this paper
• Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity.

  2003cited by this paper
• Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents.

  2003cited by this paper
• Development of Pet and Spect Radioligands for Cannabinoid Receptors

  2003cited by this paper
• Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain

  2003cited by this paper
• Synthesis of N‐(piperidin‐1‐yl)‐5‐(4‐methoxyphenyl)‐1‐(2‐chlorophenyl)‐4‐[18F]fluoro‐1H‐pyrazole‐3‐carboxamide by nucleophilic [18F] fluorination: a PET radiotracer for studying CB1 cannabinoid receptors

  2003cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002influential reference
• Carbon-11 labeled radioligands for imaging brain cannabinoid receptors.

  2002cited by this paper
• Biodistribution of [18F] SR144385 and [18F] SR147963: selective radioligands for positron emission tomographic studies of brain cannabinoid receptors.

  2000cited by this paper
• Column-switching HPLC for the analysis of plasma in PET imaging studies.

  2000cited by this paper
• Synthesis of [18F] SR144385: a selective radioligand for positron emission tomographic studies of brain cannabinoid receptors

  1999cited by this paper
• Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.

  1999cited by this paper
• Imaging the Brain Marijuana Receptor: Development of a Radioligand that Binds to Cannabinoid CB1 Receptors In Vivo

  1998cited by this paper
• Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain.

  1997cited by this paper
• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  1994cited by this paper
• Human Striatal l-DOPA Decarboxylase Activity Estimated in vivo Using 6-[18F]fluoro-DOPA and Positron Emission Tomography: Error Analysis and Application to Normal Subjects

  1993cited by this paper
• In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428

  1993cited by this paper
• PET studies in the primate brain and biodistribution in mice using (−)-5′-18F-Δ8-THC

  1991cited by this paper
• PET studies in the primate brain and biodistribution in mice using (-)-5'-18F-delta 8-THC.

  1991cited by this paper
• Cannabinoid receptor localization in brain.

  1990cited by this paper
• Movement of CO2 and HCO-3 from blood to brain in dogs.

  1983influential reference

• PET Molecular Imaging of the Endocannabinoid System in Psychiatric Disorders

  2025cites this paper
• A Preliminary Investigation of Brain Cannabinoid Receptor Type 1 (CB1R) Availability in Men with Opioid Use Disorder

  2025cites this paper
• In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration

  2025cites this paper
• [11C]HSP990 PET as a translational tool to investigate the role of Hsp90 in tumours and support the development of Hsp90 therapeutics

  2025cites this paper
• Cannabinoid 1 receptor occupancy and neurovascular responses induced by agonist, antagonist/inverse-agonist, and potential modulator in non-human primate brains: PET/fMRI study.

  2025cites this paper
• Cannabinoid 1 receptor availability in posttraumatic stress disorder: A positron emission tomography study

  2025cites this paper
• Cannabinoid Receptor Type 1 Availability in Individuals with a History of Childhood Trauma: A Positron Emission Tomography Study

  2025cites this paper
• Positron Emission Tomography Imaging of Synaptic Dysfunction in Parkinson’s Disease

  2024cites this paper
• Radiosynthesis and preclinical evaluation of [11C]SNX-ab as an Hsp90α,β isoform-selective PET probe for in vivo brain and tumour imaging

  2023cites this paper
• Recent advances in the development of CB1R selective probes

  2023cites this paper
• Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS

  2023cites this paper
• Correlation analysis of positron emission tomography/computed tomography-magnetic resonance imaging of cannabinoid type 1 receptor in the lumbar spine and brain of aged osteoporosis female cynomolgus monkeys

  2023cites this paper
• Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE

  2022cites this paper
• A Baboon Brain Atlas for Magnetic Resonance Imaging and Positron Emission Tomography Image Analysis

  2022cites this paper
• Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders

  2022cites this paper
• Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders

  2022cites this paper
• Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PET

  2022cites this paper
• Endocannabinoid System Biomarkers in Alzheimer's Disease

  2022cites this paper
• Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases.

  2021influential citation
• Translation of animal endocannabinoid models of PTSD mechanisms to humans: Where to next?

  2021cites this paper
• Synthetic Pept-Ins as a Generic Amyloid-Like Aggregation-Based Platform for In Vivo PET Imaging of Intracellular Targets

  2021cites this paper
• From Radiosynthesis Development to GMP Production

  2021cites this paper
• Automated GMP production and long-term experience in radiosynthesis of CB1 tracer [18 F]FMPEP-d2.

  2020cites this paper
• Positron Emission Tomography in the Inflamed Cerebellum: Addressing Novel Targets among G Protein-Coupled Receptors and Immune Receptors

  2020cites this paper
• PET Imaging of the Endocannabinoid System

  2020cites this paper
• Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development.

  2020cites this paper
• Quantification of the Cannabinoid Type 1 Receptor Availability in the Mouse Brain

  2020cites this paper
• Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET)

  2020cites this paper
• Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

  2019cites this paper
• Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma.

  2019cites this paper
• Novel Myocardial PET/CT Receptor Imaging and Potential Therapeutic Targets

  2019cites this paper
• Evaluation of [11C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90

  2019cites this paper
• Sex difference in brain CB1 receptor availability in man

  2019cites this paper
• New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders

  2018cites this paper
• Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach.

  2018cites this paper
• Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder

  2018cites this paper
• Whole-body biodistribution of the cannabinoid type 1 receptor ligand [18F]MK-9470 in the rat.

  2017cites this paper
• Social Stress and Psychosis Risk: Common Neurochemical Substrates?

  2016cites this paper
• A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates.

  2016cites this paper
• Rapid Changes in CB 1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis Deepak

  2016cites this paper
• Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis.

  2016cites this paper
• Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis.

  2016cites this paper
• Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.

  2016cites this paper
• Endocannabinoids and Mental Disorders.

  2015cites this paper
• Imaging the Cannabinoid CB1 Receptor in Humans with [11C] OMAR: Assessment of Kinetic Analysis Methods, Test–Retest Reproducibility, and Gender Differences

  2015cites this paper
• Synthesis and Preclinical Evaluation of [18F]FCHC for Neuroimaging of Fatty Acid Amide Hydrolase

  2015cites this paper
• Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use

  2015cites this paper
• PET in Multiple Sclerosis

  2015cites this paper
• Relationship between the adenosine A1 receptor and cGMP levels in the hippocampus: implications on neurotransmission and synaptic plasticity

  2015cites this paper
• Cannabinoids and Huntington’s disease

  2015cites this paper
• 4-Cyano-5-(2-thiophenyl)-pyrazoles are high affinity CB1 receptor ligands

  2015cites this paper
• Automated one-step radiosynthesis of the CB1 receptor imaging agent [(18) F]MK-9470.

  2014cites this paper
• Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors

  2014cites this paper
• Brain PET Imaging in the Cannabinoid System

  2014cites this paper
• Brain Imaging of Cannabinoid Receptors

  2014cites this paper
• Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia.

  2014influential citation
• Facile and high-yield synthesis of N-(4-diethylamino)benzyl-4-[¹¹C]methoxy-N-(p-tolyl)benzenesulfonamide as a new potential PET selective CB2 radioligand.

  2014cites this paper
• In vivo type 1 cannabinoid receptor availability in Alzheimer's disease.

  2014cites this paper
• Retraction Note: Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors

  2014cites this paper
• PET Imaging of Endocannabinoid System

  2014cites this paper
• Test–retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [11C]MePPEP

  2014cites this paper
• Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor.

  2014cites this paper
• Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice

  2014cites this paper
• Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase.

  2013cites this paper
• New Perspectives in Nuclear Neurology for the Evaluation of Parkinson's Disease

  2013cites this paper
• PET Studies of Neurotransmission in Temporal Lobe Epilepsy

  2013cites this paper
• Radiofluorination and biological evaluation of N-aryl-oxadiazolyl-propionamides as potential radioligands for PET imaging of cannabinoid CB2 receptors

  2013cites this paper
• The Role of Positron Emission Imaging (PET) in Understanding Addiction

  2013cites this paper
• cannabinoid receptor in prostate carcinoma: a pilot study

  2013cites this paper
• Endocannabinoid system: potential novel targets for treatment of schizophrenia.

  2013cites this paper
• Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans

  2013cites this paper
• Elevated Brain Cannabinoid CB1 Receptor Availability in Posttraumatic Stress Disorder: A Positron Emission Tomography Study

  2013cites this paper
• Neurochemistry of Placebo Analgesia: Opioids, Cannabinoids and Cholecystokinin

  2013cites this paper
• Evaluation of cannabinoid type 1 receptor expression in the rat brain using [18F]MK-9470 microPET

  2013cites this paper
• 18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study

  2013cites this paper
• Long-Term Exposure to Oral Methylphenidate or dl-Amphetamine Mixture in Peri-Adolescent Rhesus Monkeys: Effects on Physiology, Behavior, and Dopamine System Development

  2012cites this paper
• A new high-yield synthetic route to PET CB1 radioligands [11C]OMAR and its analogs.

  2012cites this paper
• Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence.

  2012cites this paper
• Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer.

  2012cites this paper
• Preclinical evaluation and quantification of [18F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain

  2012cites this paper
• Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.

  2012cites this paper
• [¹²⁵I]SD-7015 reveals fine modalities of CB₁ cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease.

  2012influential citation
• Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.

  2011cites this paper
• Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors

  2011cites this paper
• Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception.

  2011cites this paper
• Positron Emission Tomographic Imaging of the Cannabinoid Type 1 Receptor System with [11C]OMAR ([11C]JHU75528): Improvements in Image Quantification Using Wild-Type and Knockout Mice

  2011influential citation
• The application of PET technique for the development and evaluation of novel antipsychotics.

  2010cites this paper
• Radiosynthesis of novel carbon-11-labeled triaryl ligands for cannabinoid-type 2 receptor.

  2010cites this paper
• Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder

  2010cites this paper
• Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR

  2010influential citation
• Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEP.

  2010cites this paper
• Synthesis and in vitro biological evaluation of carbon-11-labeled quinoline derivatives as new candidate PET radioligands for cannabinoid CB2 receptor imaging.

  2010cites this paper
• Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: Test-retest reproducibility and gender differences

  2010cites this paper
• Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT

  2009cites this paper
• Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity.

  2009cites this paper
• Toward the design of cannabinoid CB1 receptor inverse agonists and neutral antagonists

  2009cites this paper
• Recent CB1 cannabinoid receptor antagonists and inverse agonists

  2009cites this paper
• Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.

  2009cites this paper
• Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand

  2009influential citation
• Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type‐1 receptors in vivo

  2009cites this paper